RAMASWAMI RAJIV

Nutanix CEO Rajiv Ramaswami sells 144.7K shares for $11.1M at $76.42 average, reducing holdings 21.6%

Rajiv Ramaswami, President and CEO of Nutanix, executed 2 separate sales totaling 144,707 shares for $11,059,200.69 on 2025-10-02, reducing his holdings from 669,315 shares to 524,608 shares (a reduction of -21.6% vs pre-transaction holdings). The blended average transaction price of $76.42 sits just 0.20 above the current price of $76.22, and within the 52-week range of $56.46–$83.07 (currently -8.2% from the 52-week high). At this ticker (NTNX), the CEO's 5 prior trades show mixed timing outcomes: 2 of 5 prior sells were well-timed at the 90-day mark; the most recent prior sale on 2025-05-13 experienced a -6.8% 30-day return and -12.9% 90-day return. The company's fundamentals show strong growth (annual revenue growth +18.1%) with $639.0M quarterly revenue and $63.4M net income, though the stock trades at a P/E of 60.98, indicating elevated valuation relative to current earnings. The sale removes a material position stake while the stock remains near recent transaction-price levels.

NTNX CEO Ramaswami sells 61.1K shares at $79.00 (−10.9% of holdings); stock now $81.83, near 52-week high.

President and CEO Rajiv Ramaswami sold 61,057 shares of Nutanix for $4,823,503.00 on 2025-05-13, reducing his holdings to 497,309 shares (497.3K shares). The sale occurred at $79.00 per share, which was 3.46% below the current price of $81.83 and 4.05% below the 52-week high of $82.40. In the same-ticker history at NTNX, Ramaswami's 4 prior measurable sells (2024–early 2025) all resulted in positive 90-day returns (ranging from +3.5% to +9.5%), meaning the stock rose after each sale; 0 of 4 prior sales were well-timed at the 90-day mark. His cross-ticker track record shows 15 prior sells with a 14.29% well-timed rate, slightly above random. The company posted revenue of $654,721,000.00 and net income of $56,427,000.00 in the latest quarter, with annual revenue growth of +15.4%, but was unprofitable over its most recent full fiscal year. Context includes a sharp 30-day price surge of +35.5% preceding the sale, suggesting the transaction occurred near a local peak relative to the recent momentum, though the stock remains within its 52-week range.

CEO Rajiv Ramaswami sold 7,740 shares of NTNX at $75.00 for $580,500; holds 558,366 shares post-transaction.

Ramaswami sold 7,740 shares (1.4% of pre-transaction holdings) at $75.00 on 2025-03-24, just 26 basis points below the current price of $74.92 and only 3.2% below the 52-week high of $77.44. His prior five trades at NTNX have not exhibited well-timed selling: 0 of 4 measurable prior sales showed negative 90-day returns, meaning the stock rose after he sold each time. At the cross-ticker level, his track record shows an average 90-day return of +19.0% following sells, with a well-timed rate of 15.38%, indicating his prior sales have generally been poorly timed relative to subsequent price movements. The company reported quarterly revenue of $654,721,000 and net income of $56,427,000, while full-year net income was negative; annual revenue growth was +15.4%, but the company is operating with the weight of prior-year losses. The sale occurs in a context where the stock is up 16.2% over 90 days, suggesting a near-term bullish momentum that may contextualize this particular exit.

CEO Rajiv Ramaswami sold 95,852 NTNX shares for $6.7M; holds 540,463 shares post-sale as stock climbs 14% in 30 days.

CEO Rajiv Ramaswami executed a substantial open-market sale of 95,852 shares at $70.00, reducing his holdings by 15.1% to 540,463 shares, even as Nutanix stock has appreciated 14.0% over the preceding 30 days. His cross-ticker track record shows a 90-day well-timed sell rate of 18.18%, but his same-ticker history at NTNX is mixed: only 1 of 3 prior measurable sales registered a negative 90-day return (well-timed), while 2 of 3 showed gains after the sale. The company remains unprofitable on a full-year basis despite 15.4% annual revenue growth and recent quarterly profitability of $29.9M, creating a divergence between growth trajectory and bottom-line sustainability. The sale's execution near the 52-week high ($73.37, just 3.4% away) warrants investor attention to whether the CEO's disposition reflects confidence in near-term momentum or concerns about valuation sustainability at these levels.

CEO Ramaswami sells 63,901 shares for $4,208,026.12 at $65.85 average; retains 649,034 shares post-sale

Rajiv Ramaswami, President and CEO, executed two separate sales on 2024-12-16 totaling 63,901 shares (representing a -9.0% reduction from his pre-transaction holdings of 712,935 shares) for $4,208,026.12 at a blended average price of $65.85. The current stock price is $66.14, placing the transaction prices just below today's market level, in the context of a 52-week range of $44.90–$73.37. Ramaswami's prior sales at NTNX showed mixed timing outcomes (2 of 5 prior sells were well-timed at the 90-day mark), and his cross-ticker track record shows an 18.18% 90-day well-timed rate across 11 prior sells. The company reported latest-quarter revenue of $590,956,000.00 with net income of $29,926,000.00, though it remains unprofitable on a full-year basis. The sale reduces but does not eliminate his substantial equity stake, maintaining material alignment with shareholder interests.

Nutanix CEO Rajiv Ramaswami sold 23,986 shares for $1.3M at $54.19 on 2024-06-18; stock down 24.0% in 30 days, -27.2% from 52-week high.

Ramaswami executed 2 separate sales totaling 23,986 shares for $1,299,737.52 at blended average price $54.19, reducing his holdings by 5.6% to 407,045 shares. The sale occurred as NTNX has declined sharply: -24.0% over the 30 days following the transaction and -27.2% from its 52-week high of $73.37. Critically, the company is unprofitable (net income $-15,616,000.00 in the latest quarter), which compounds concern over the stock's deteriorating momentum. His cross-ticker track record shows a 22.22% well-timed rate on prior sells, but at NTNX specifically, only 2 of 5 prior sales were well-timed at the 90-day mark—a 40% success rate that falls below his cross-ticker performance.